Registry for people getting a tricuspid valve repair
Part of Heart & circulation clinical trials.
This trial is a national registry that collects information about people undergoing a minimally invasive tricuspid valve repair using a catheter. It helps doctors learn how this procedure is used and how patients do over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old
- Your heart team must say you are eligible for a tricuspid valve repair using a catheter
- You must be willing and able to sign an informed consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults with leaky or narrowed heart valves who are being considered for a valve procedure. It helps doctors better understand patient outcomes and care decisions for these valve problems.
This trial is a registry that collects information on patients who have had a minimally invasive procedure to fix a leaky tricuspid valve. By joining, you help doctors learn more about how well these devices work over time.
This study collects information about people who are having a transcatheter tricuspid valve procedure (a heart valve treatment done through catheters rather than open-heart surgery). It may help doctors understand safety and outcomes better over time.
This study is a registry that collects data on patients who receive a new type of heart valve replacement for the tricuspid valve through a less invasive catheter procedure. Joining helps doctors learn more about how well this treatment works in real-world patients.
This study is collecting information about people with severe tricuspid regurgitation (a leaky heart valve) who are having a catheter-based repair. The goal is to better understand these patients and how well the procedure works for them.
This study tracks patients with weak heart pumps and leaky tricuspid valves (a valve on the right side of the heart) who receive a minimally invasive repair procedure. The goal is to understand how this treatment affects patients' heart function and quality of life over time.
Hear when a new Tricuspid Valve Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.